Genetics of caffeine consumption and responses to caffeine

RationaleCaffeine is widely consumed in foods and beverages and is also used for a variety of medical purposes. Despite its widespread use, relatively little is understood regarding how genetics affects consumption, acute response, or the long-term effects of caffeine.ObjectiveThis paper reviews the literature on the genetics of caffeine from the following: (1) twin studies comparing heritability of consumption and of caffeine-related traits, including withdrawal symptoms, caffeine-induced insomnia, and anxiety, (2) association studies linking genetic polymorphisms of metabolic enzymes and target receptors to variations in caffeine response, and (3) case-control and prospective studies examining relationship between polymorphisms associated with variations in caffeine response to risks of Parkinson’s and cardiovascular diseases in habitual caffeine consumers.ResultsTwin studies find the heritability of caffeine-related traits to range between 0.36 and 0.58. Analysis of polysubstance use shows that predisposition to caffeine use is highly specific to caffeine itself and shares little common disposition to use of other substances. Genome association studies link variations in adenosine and dopamine receptors to caffeine-induced anxiety and sleep disturbances. Polymorphism in the metabolic enzyme cytochrome P-450 is associated with risk of myocardial infarction in caffeine users.ConclusionModeling based on twin studies reveals that genetics plays a role in individual variability in caffeine consumption and in the direct effects of caffeine. Both pharmacodynamic and pharmacokinetic polymorphisms have been linked to variation in response to caffeine. These studies may help guide future research in the role of genetics in modulating the acute and chronic effects of caffeine.

[1]  D. Giles,et al.  Beta EEG activity and insomnia. , 2001, Sleep medicine reviews.

[2]  M. Raiteri,et al.  Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes , 2002, British journal of pharmacology.

[3]  M. Schwarzschild,et al.  Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease , 2001, The Journal of Neuroscience.

[4]  P. Tuite,et al.  Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005) , 2008, Annals of neurology.

[5]  L. Andersen,et al.  Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. , 2006, The American journal of clinical nutrition.

[6]  K. Kendler,et al.  Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. , 2007, Archives of general psychiatry.

[7]  D. Charney,et al.  Increased anxiogenic effects of caffeine in panic disorders. , 1985, Archives of general psychiatry.

[8]  A. El-Sohemy,et al.  Coffee, CYP1A2 genotype, and risk of myocardial infarction. , 2006, JAMA.

[9]  J. Badner,et al.  Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety , 2008, Neuropsychopharmacology.

[10]  R. Freire,et al.  Panic disorder and social anxiety disorder subtypes in a caffeine challenge test , 2009, Psychiatry Research.

[11]  R. Williams,et al.  Caffeine effects on cardiovascular and neuroendocrine responses to acute psychosocial stress and their relationship to level of habitual caffeine consumption. , 1990, Psychosomatic medicine.

[12]  E. Hattori,et al.  Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder , 2001, Journal of Neural Transmission.

[13]  D. Grobbee,et al.  Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials , 2005, Journal of hypertension.

[14]  E. M. Adler,et al.  Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. , 1992, Brain research. Molecular brain research.

[15]  Michael F. Wilson,et al.  Hypertension risk status and effect of caffeine on blood pressure. , 2000, Hypertension.

[16]  M. Morelli,et al.  Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors , 2000, Behavioural Brain Research.

[17]  Harvey Checkoway,et al.  Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. , 2002, American journal of epidemiology.

[18]  N. Shahidi.  Acetophenetidin sensitivity. , 1967, American journal of diseases of children.

[19]  H. Kase,et al.  In vivo regulation of acetylcholine release via adenosine A1 receptor in rat cerebral cortex , 1996, Neuroscience Letters.

[20]  T. Spector,et al.  Dietary Patterns and Heritability of Food Choice in a UK Female Twin Cohort , 2007, Twin Research and Human Genetics.

[21]  H. Lieberman,et al.  The effects of low doses of caffeine on human performance and mood , 2004, Psychopharmacology.

[22]  J. Palacios,et al.  Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease , 1991, Neuroscience.

[23]  B. Shukitt-Hale,et al.  Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training , 2002, Psychopharmacology.

[24]  A. J. Carter,et al.  Caffeine enhances acetylcholine release in the hippocampus in vivo by a selective interaction with adenosine A1 receptors. , 1995, The Journal of pharmacology and experimental therapeutics.

[25]  M. Dogui,et al.  Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects. , 2006, Comptes rendus biologies.

[26]  N. Martin,et al.  Symptoms of anxiety and symptoms of depression. Same genes, different environments? , 1987, Archives of general psychiatry.

[27]  N. Benowitz,et al.  Clinical pharmacology of caffeine. , 1990, Annual review of medicine.

[28]  J. Idle,et al.  The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition. , 1983, British journal of clinical pharmacology.

[29]  K. Kendler,et al.  Twin studies of psychiatric illness. Current status and future directions. , 1993, Archives of general psychiatry.

[30]  A. Staphorsius,et al.  A Genetic Analysis of Coffee Consumption in a Sample of Dutch Twins , 2009, Twin Research and Human Genetics.

[31]  M. Bracken,et al.  Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. , 2005, Annals of epidemiology.

[32]  G. Kearns,et al.  Quantitation of three‐month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N‐acetyltransferase‐2, and xanthine oxidase activity determined with caffeine phenotyping , 1998, Clinical pharmacology and therapeutics.

[33]  M. Lader,et al.  Anxiogenic effects of caffeine in patients with anxiety disorders. , 1992, Archives of general psychiatry.

[34]  J. Brockmöller,et al.  Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. , 1999, British journal of clinical pharmacology.

[35]  W. Willett,et al.  Prospective study of caffeine consumption and risk of Parkinson's disease in men and women , 2001, Annals of neurology.

[36]  S. Fook-Chong,et al.  Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[37]  Silvio Garattini,et al.  Caffeine, coffee, and health , 1993 .

[38]  B. Fredholm,et al.  Caffeine--an atypical drug of dependence. , 1998, Drug and alcohol dependence.

[39]  Graeme Milligan,et al.  Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers , 2006, The Journal of Neuroscience.

[40]  R. Griffiths,et al.  Low-dose caffeine discrimination and self-reported mood effects in normal volunteers. , 1992, Journal of the experimental analysis of behavior.

[41]  P. Smits,et al.  Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. , 2009, Pharmacology & therapeutics.

[42]  Shih-Jen Tsai,et al.  Association study of A2a adenosine receptor genetic polymorphism in panic disorder , 2005, Neuroscience Letters.

[43]  Rachel K. Johnson,et al.  Food sources and intakes of caffeine in the diets of persons in the United States. , 2005, Journal of the American Dietetic Association.

[44]  Michael F. Wilson,et al.  Blood Pressure Response to Caffeine Shows Incomplete Tolerance After Short-Term Regular Consumption , 2004, Hypertension.

[45]  K. Kendler,et al.  A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins. , 1999, Drug and alcohol dependence.

[46]  Ahmed El-Sohemy,et al.  Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. , 2007, The American journal of clinical nutrition.

[47]  Roland R. Griffiths,et al.  Reinforcing effects of caffeine in humans , 1988, Pharmacology Biochemistry and Behavior.

[48]  Oliver G. Cameron,et al.  Anxiety and caffeine consumption in people with anxiety disorders , 1985, Psychiatry Research.

[49]  R. Korpela,et al.  Coffee, caffeine and blood pressure: a critical review , 1999, European Journal of Clinical Nutrition.

[50]  D. Carmelli,et al.  Heritability of substance use in the NAS-NRC Twin Registry. , 1990, Acta geneticae medicae et gemellologiae.

[51]  K. Kendler,et al.  Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. , 1999, The American journal of psychiatry.

[52]  M. Morelli,et al.  Caffeine and the dopaminergic system , 2005, Behavioural pharmacology.

[53]  R Workman,et al.  Tolerance to the humoral and hemodynamic effects of caffeine in man. , 1981, The Journal of clinical investigation.

[54]  P. Smits,et al.  The cardiovascular effects of regular and decaffeinated coffee. , 1985, British journal of clinical pharmacology.

[55]  N. Martin,et al.  "No thanks, it keeps me awake": the genetics of coffee-attributed sleep disturbance. , 2007, Sleep.

[56]  J. Miners,et al.  Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. , 1986, British journal of clinical pharmacology.

[57]  T. Shimoda,et al.  Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma , 2003, Clinical pharmacology and therapeutics.

[58]  P. Greengard,et al.  Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2a receptor signaling in the neostriatum , 2006, Neuroscience.

[59]  K. Kendler,et al.  Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. , 2008, Archives of general psychiatry.

[60]  E. Noble,et al.  Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review , 2000, European Psychiatry.

[61]  M. Nöthen,et al.  Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease , 1998, Molecular Psychiatry.

[62]  H. Landolt,et al.  A Genetic Variation in the Adenosine A2A Receptor Gene (ADORA2A) Contributes to Individual Sensitivity to Caffeine Effects on Sleep , 2007, Clinical pharmacology and therapeutics.

[63]  M. Parmentier,et al.  Reduced appetite for caffeine in adenosine A(2A) receptor knockout mice. , 2005, European journal of pharmacology.

[64]  C. Tanner,et al.  Association of coffee and caffeine intake with the risk of Parkinson disease. , 2000, JAMA.

[65]  A. Vincent,et al.  Hemodynamic mechanisms underlying the incomplete tolerance to caffeine's pressor effects. , 2005, The American journal of cardiology.

[66]  D. Gillings,et al.  Caffeine as an analgesic adjuvant in tension headache , 1994, Clinical pharmacology and therapeutics.

[67]  F. Berthou,et al.  Caffeine increases its own metabolism through cytochrome P4501A induction in rats. , 1995, Life sciences.

[68]  P. Richardson,et al.  Adenosine A2a Receptor‐Mediated Modulation of Striatal [3H]GABA and [3H]Acetylcholine Release , 1994, Journal of neurochemistry.

[69]  B. Pitt.  Psychopharmacology , 1968, Mental Health.

[70]  T. Dunwiddie,et al.  The Role and Regulation of Adenosine in the Central Nervous System , 2022 .

[71]  K. Kyvik,et al.  The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. , 2002, Pharmacogenetics.

[72]  N. Martin,et al.  Heritability and genetic covariation of sensitivity to PROP, SOA, quinine HCl, and caffeine. , 2006, Chemical senses.

[73]  B. Fredholm,et al.  Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. , 1999, Pharmacological reviews.

[74]  L. Cardon,et al.  Heavy consumption of cigarettes, alcohol and coffee in male twins. , 1997, Journal of studies on alcohol.

[75]  James O. Mudd,et al.  Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. , 2009, Journal of the American College of Cardiology.

[76]  L F Agnati,et al.  Receptor heteromerization in adenosine A2A receptor signaling , 2003, Neurology.

[77]  G. Friedman,et al.  Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk. , 1990, American journal of epidemiology.

[78]  E. Ongini,et al.  Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats , 1998, Neuroreport.

[79]  L. Cardon,et al.  The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis. , 1996, Journal of substance abuse.

[80]  J Patel,et al.  Effects of chronic caffeine on brain adenosine receptors: regional and ontogenetic studies. , 1984, Life sciences.

[81]  Susan E Hodge,et al.  Evidence for Genetic Linkage Between a Polymorphism in the Adenosine 2A Receptor and Panic Disorder , 2004, Neuropsychopharmacology.

[82]  J. Kaprio,et al.  Genetics of coffee consumption and its stability. , 2008, Addiction.

[83]  A. Gunes,et al.  Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. , 2008, Pharmacogenomics.

[84]  Kimon S Stamatelopoulos,et al.  Effect of coffee on endothelial function in healthy subjects: the role of caffeine. , 2005, Clinical science.

[85]  Y. Chern,et al.  A critical evaluation of adenosine A2A receptors as potentially "druggable" targets in Huntington's disease. , 2008, Current pharmaceutical design.

[86]  D. Robertson,et al.  The Cardiovascular Effects of Caffeine , 1984 .

[87]  M. Arnaud.  The pharmacology of caffeine. , 1987, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[88]  R. Griffiths,et al.  Caffeine tolerance and choice in humans , 1992, Psychopharmacology.

[89]  J Patel,et al.  Chronic caffeine consumption increases the number of brain adenosine receptors. , 1983, Life sciences.

[90]  P. Sand,et al.  Association Between A2a Receptor Gene Polymorphisms and Caffeine-Induced Anxiety , 2003, Neuropsychopharmacology.

[91]  M. Low,et al.  Functional Uncoupling of Adenosine A2A Receptors and Reduced Response to Caffeine in Mice Lacking Dopamine D2Receptors , 2000, The Journal of Neuroscience.

[92]  A. de Mendonça,et al.  Does caffeine intake protect from Alzheimer's disease? , 2002, European journal of neurology.

[93]  Arne Ohlsson,et al.  Long-term effects of caffeine therapy for apnea of prematurity. , 2007, The New England journal of medicine.

[94]  R. Griffiths,et al.  The Role of Dopamine in the Behavioral Effects of Caffeine in Animals and Humans , 1997, Pharmacology Biochemistry and Behavior.

[95]  M. Raiteri,et al.  Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes , 2002 .

[96]  S. Ferré.  An update on the mechanisms of the psychostimulant effects of caffeine , 2008, Journal of neurochemistry.

[97]  G. Colditz,et al.  Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. , 1994, British heart journal.

[98]  L. Defebvre,et al.  A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease , 2009, Neurobiology of Disease.

[99]  J. Miners,et al.  The use of caffeine as a metabolic probe for human drug metabolizing enzymes. , 1996, General pharmacology.

[100]  A. Thapar,et al.  Methodology for Genetic Studies of Twins and Families , 1993 .

[101]  H. Kuribara.  Modification by caffeine of the sensitization to methamphetamine and cocaine in terms of ambulation in mice. , 1994, Life sciences.

[102]  J. Daly,et al.  Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthines , 1983, Cellular and Molecular Neurobiology.

[103]  N. Martin,et al.  The genetics of tea and coffee drinking and preference for source of caffeine in a large community sample of Australian twins. , 2005, Addiction.

[104]  J. Gaillard,et al.  Spectral characteristics of sleep EEG in chronic insomnia , 1998, The European journal of neuroscience.

[105]  F. Sofi,et al.  Coffee consumption and risk of coronary heart disease: a meta-analysis. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[106]  P. Whelton,et al.  The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. , 1999, Hypertension.

[107]  D. Kennedy,et al.  Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine , 2005, Psychopharmacology.

[108]  K. Jacobson,et al.  Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain , 1993, Cellular and Molecular Neurobiology.

[109]  G. Fisone,et al.  Caffeine as a psychomotor stimulant: mechanism of action , 2004, Cellular and Molecular Life Sciences CMLS.

[110]  B. Tang,et al.  Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities , 1991, Clinical pharmacology and therapeutics.

[111]  Tomi-Pekka Tuomainen,et al.  Catechol-O-Methyltransferase Gene Polymorphism Modifies the Effect of Coffee Intake on Incidence of Acute Coronary Events , 2006, PloS one.

[112]  B. Fredholm,et al.  Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine , 2005, Nature Neuroscience.

[113]  Gerome Breen,et al.  Genetic Variation , 2020, Population Genetics with R.

[114]  J. A. Swanson,et al.  Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. , 1994, Addictive behaviors.

[115]  E. Cook,et al.  Interindividual variation in anxiety response to amphetamine: Possible role for adenosine A2A receptor gene variants , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[116]  D. Maraganore,et al.  Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[117]  O. Cameron,et al.  Anxiogenic effects of caffeine on panic and depressed patients. , 1988, The American journal of psychiatry.